Topics
High-grade gliomas | Prognosis | H3 G34-mutant
Home > Publications > Topics > High-grade gliomas > Prognosis > H3 G34-mutant
Crowell C, Mankuzhy NP, Bennett J, Bandopadhayay P, Sturm D, Green
AL, Gupta T, Chatterjee A, Epari S, Chinnaswamy G, Prasad M, Patel
SH, MacNeil M, Vanan MI, Larouche V, Renzi S, Jones J, Perreault
S, Mata-Mbemba D, Sangatsuda Y, Yoshimoto K, Lin E, Feddersen C,
Cruz O, Pavon-Mengual M, Vizzini O, Zápotocký M,
Popovacki A, Klawinski D, Hansford JR, Schlosser MP, Omene E,
Alexander KL, Satgunaseelan L, Williams A, Yao K, Ronsley R, Cheng
S, Ludlow L, Eisenstat D, Khuong-Quang DA, Tabouret E, André
N, Matheson K, Chan A, Lim-Fat MJ, Lapointe S, Cayrol R, Coleman
C, Juretic N, McThenia S, Khan S, Wright-Nadkarni M, Salloum R,
Galvin RT, Sener U, Hawkins C, Imber BS, Karajannis MA, Jones DTW,
Ligon KL, Jabado N, Erker C.
Clinical
Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3
G34-mutant: An International Multi-Institutional Study.
Clin
Cancer Res. 2026 Mar 9. doi:
10.1158/1078-0432.CCR-25-3764. PMID:
41801141. ˍ